To review four cases of combined hepatic and renal toxicity that may be associated with the administration of nafcillin in adults. This type of adverse event with the use of nafcillin has not been previously documented in the literature.
DATA SOURCES:
References from pertinent articles are identified throughout the text.
DATA SYNTHESIS:
Nafcillin is a widely used penicillinase-resistant penicillin. In four patients receiving nafcillin doses greater than 9 g/24 hours, changes in renal and hepatic function markers were noted within 72 hours of the initiation of nafcillin therapy. Laboratory values returned toward baseline when nafcillin therapy was discontinued. Elevations in blood urea nitrogen, creatinine, total bilirubin, and lactate dehydrogenase have been previously described in the literature for penicillin-like agents other than nafcillin. The exact mechanism for such toxicities as well as patient risk factors have not been clearly established.
CONCLUSIONS:
Caution should be taken when initiating nafcillin therapy. Evaluation of renal and liver function tests prior to initiating nafcillin therapy and within the first 72 hours appears warranted. If hepatic and/or renal toxicity is observed, discontinuation of nafcillin should be considered.
Get full access to this article
View all access options for this article.
References
1.
Ten PasAQuinnEL. Cholestatic hepatitis following the administration of sodium oxacillin. JAMA1965; 191: 138–9.
2.
EnatRPollackSBen-AriehYLivniEBarzilaiD. Cholestatic jaundice caused by cloxacillin: Macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs. Br Med J1980; 280: 982–3.
3.
KonikoffFAlcalayJHalevyJ. Cloxacillin-induced cholestatic jaundice. Am J Gastroenterol1986; 81: 1082–3.
Valdivia-BarrigaVFeldmanAOrellanaJ. Generalized hypersensitivity with hepatitis and jaundice after the use of penicillin and streptomycin. Gastroenterology1963; 45: 114–7.
MillerWISouneyPFChangJT. Hepatic dysfunction following nafcillin and cephalothin therapy in a patient with a history of oxacillin hepatitis. Clin Pharm1983; 2: 465–8.
24.
BaldwinDSLevineBBMcCluskeyRTGalloGR. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med1968; 279: 1245–52.
25.
GalpinJEShinabergerJHStanleyTMBlumenkrantzMJBayerASFriedmanGSAcute interstitial nephritis due to methicillin. Am J Med1978; 65: 756–65.
26.
SimenhoffMLGuildWRDamminGJ. Acute diffuse interstitial nephritis. Am J Med1968; 44: 618–25.
IsacsonJCollertS. Renal impairment after high doses of dicloxacillin-prophylaxis in joint replacement surgery. Acta Orthop Scand1984; 55: 407–10.
34.
EngCJavittNB. Effect of nafcillin on hepatic excretory function. Biochem Pharmacol1983; 32: 3649–51.
35.
FishbachFT. A manual of laboratory diagnostic tests. 3rd ed.Philadelphia: JB Lippincott, 1988: 317–8.
36.
JimLK. Hepatic disorders. Part I: Adverse effects of drugs on the liver. In: YoungLYKoda-KimbleMA, eds. Applied therapeutics: The clinical use of drugs. 4th ed. Vancouver, WA: Applied Therapeutics, 1988: 489–95.
37.
HoganDBMorinJCrillyRG. Unusual hepatotoxic reaction to quinidine (letter). Can Med Assoc J1984; 130: 973.
38.
TabibianNAlpertLAlpertE. Captopril-induced liver dysfunction. South Med J1987; 80: 1173–5.
39.
BakerDE. Drug-induced renal disorders. In: YoungLYKoda-KimbleMA, eds. Applied therapeutics: The clinical use of drugs. 4th ed. Vancouver, WA: Applied Therapeutics, 1988: 601–22.
